- Home
- ASPI vs CYRX Comparison
ASPI vs CYRX Comparison
Compare ASPI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- CYRX
- Stock Information
- Founded
- ASPI 2021
- CYRX 1999
- Country
- ASPI United States
- CYRX United States
- Employees
- ASPI N/A
- CYRX N/A
- Industry
- ASPI Major Chemicals
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASPI Industrials
- CYRX Health Care
- Exchange
- ASPI Nasdaq
- CYRX Nasdaq
- Market Cap
- ASPI 298.8M
- CYRX 310.4M
- IPO Year
- ASPI 2022
- CYRX N/A
- Fundamental
- Price
- ASPI $4.82
- CYRX $6.09
- Analyst Decision
- ASPI Strong Buy
- CYRX Strong Buy
- Analyst Count
- ASPI 2
- CYRX 6
- Target Price
- ASPI $4.50
- CYRX $11.50
- AVG Volume (30 Days)
- ASPI 1.4M
- CYRX 663.5K
- Earning Date
- ASPI 05-14-2025
- CYRX 05-06-2025
- Dividend Yield
- ASPI N/A
- CYRX N/A
- EPS Growth
- ASPI N/A
- CYRX N/A
- EPS
- ASPI N/A
- CYRX N/A
- Revenue
- ASPI $4,144,225.00
- CYRX $228,385,000.00
- Revenue This Year
- ASPI $865.76
- CYRX $9.18
- Revenue Next Year
- ASPI $700.00
- CYRX $8.65
- P/E Ratio
- ASPI N/A
- CYRX N/A
- Revenue Growth
- ASPI 857.04
- CYRX N/A
- 52 Week Low
- ASPI $1.86
- CYRX $4.58
- 52 Week High
- ASPI $9.33
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- ASPI 53.92
- CYRX 47.99
- Support Level
- ASPI $3.92
- CYRX $5.90
- Resistance Level
- ASPI $4.81
- CYRX $7.00
- Average True Range (ATR)
- ASPI 0.45
- CYRX 0.61
- MACD
- ASPI 0.10
- CYRX 0.03
- Stochastic Oscillator
- ASPI 67.72
- CYRX 35.88
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.